JP2023514452A5 - - Google Patents
Info
- Publication number
- JP2023514452A5 JP2023514452A5 JP2022550908A JP2022550908A JP2023514452A5 JP 2023514452 A5 JP2023514452 A5 JP 2023514452A5 JP 2022550908 A JP2022550908 A JP 2022550908A JP 2022550908 A JP2022550908 A JP 2022550908A JP 2023514452 A5 JP2023514452 A5 JP 2023514452A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062981453P | 2020-02-25 | 2020-02-25 | |
| US62/981,453 | 2020-02-25 | ||
| US202063002249P | 2020-03-30 | 2020-03-30 | |
| US63/002,249 | 2020-03-30 | ||
| US202062706225P | 2020-08-05 | 2020-08-05 | |
| US62/706,225 | 2020-08-05 | ||
| US202063091291P | 2020-10-13 | 2020-10-13 | |
| US63/091,291 | 2020-10-13 | ||
| PCT/US2021/019739 WO2021173879A1 (en) | 2020-02-25 | 2021-02-25 | Identification of biomimetic viral peptides and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023514452A JP2023514452A (ja) | 2023-04-05 |
| JP2023514452A5 true JP2023514452A5 (https=) | 2024-03-05 |
| JPWO2021173879A5 JPWO2021173879A5 (https=) | 2024-03-05 |
Family
ID=77492020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022550908A Withdrawn JP2023514452A (ja) | 2020-02-25 | 2021-02-25 | 生体模倣ウイルスペプチドの特定及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230242592A1 (https=) |
| EP (1) | EP4110366A4 (https=) |
| JP (1) | JP2023514452A (https=) |
| KR (1) | KR20220158723A (https=) |
| CN (1) | CN115461068A (https=) |
| AU (1) | AU2021227918A1 (https=) |
| CA (1) | CA3172878A1 (https=) |
| IL (1) | IL295863A (https=) |
| WO (1) | WO2021173879A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CR20220552A (es) | 2020-04-02 | 2023-01-17 | Regeneron Pharma | Anticuerpos contra glicoproteína de espícula anti-sars-cov-2 y fragmentos de unión al antígeno |
| US20230218742A1 (en) * | 2020-05-22 | 2023-07-13 | Riken | Multiple antigenic peptide against coronavirus and immunostimulating composition containing the same |
| CA3181026A1 (en) | 2020-06-03 | 2021-12-09 | Samit GANGULY | Methods for treating or preventing sars-cov-2 infections and covid-19 with anti-sars-cov-2 spike glycoprotein antibodies |
| IL310012A (en) | 2021-07-14 | 2024-03-01 | Regeneron Pharma | Antibodies against SARS-COV-2 spike glycoprotein and antigen-binding fragments |
| WO2023044494A2 (en) | 2021-09-17 | 2023-03-23 | Kotlyar David | Oral vaccine via dental bacteria and emitted peptides to prevent covid-19 infection |
| IT202200025416A1 (it) * | 2022-12-13 | 2024-06-13 | Univ Pisa | Biosensore per la rilevazione di particelle virali |
| CN117153245B (zh) * | 2023-10-18 | 2024-03-19 | 无锡市疾病预防控制中心 | 预测新型冠状病毒S蛋白RBD区域与hACE2受体相互作用的方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017046801A1 (en) * | 2015-09-17 | 2017-03-23 | Ramot At Tel-Aviv University Ltd. | Coronaviruses epitope-based vaccines |
| CN110582301A (zh) * | 2016-12-14 | 2019-12-17 | 利甘达尔股份有限公司 | 用于核酸和蛋白质有效负载递送的方法和组合物 |
| US11365239B2 (en) * | 2020-03-20 | 2022-06-21 | Tsb Therapeutics (Beijing) Co., Ltd. | Anti-SARS-COV-2 antibodies and uses thereof |
-
2021
- 2021-02-25 IL IL295863A patent/IL295863A/en unknown
- 2021-02-25 KR KR1020227033145A patent/KR20220158723A/ko active Pending
- 2021-02-25 AU AU2021227918A patent/AU2021227918A1/en active Pending
- 2021-02-25 EP EP21760562.5A patent/EP4110366A4/en active Pending
- 2021-02-25 CN CN202180031498.6A patent/CN115461068A/zh active Pending
- 2021-02-25 JP JP2022550908A patent/JP2023514452A/ja not_active Withdrawn
- 2021-02-25 CA CA3172878A patent/CA3172878A1/en active Pending
- 2021-02-25 WO PCT/US2021/019739 patent/WO2021173879A1/en not_active Ceased
-
2022
- 2022-08-24 US US17/822,099 patent/US20230242592A1/en active Pending